August 18th, 2025: FDA Flags Rising Safety Concerns Over Compounded and Counterfeit Ozempic and GLP-1 Drugs The FDA has issued a new warning highlighting the dangers of unapproved and compounded GLP-1 receptor agonists, including versions of semaglutidethe active ingredient in Ozempic and Wegovy
An Advanced Research Tool in Regenerative Healing Unlock new dimensions in regenerative medicine research with the Bond Peptides BPC-157 + TB-500 Capsules
If your vial does not have a visible BUD, contact the pharmacy immediately
Plan around known disruptions If you know a vacation, work trip, or medical procedure is coming, adjust your schedule proactively
Scientific Activity It binds a class B1 G-protein-coupled receptor and activates Gs, adenylyl cyclase, and cyclic AMP signaling in research assays
These hormones trigger insulin release, suppress appetite, slow gastric emptying, and increase satiety (the feeling of fullness)